A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model
Runa Takahashi(Hokkaido Pharmaceutical University), Yuichi Kitai(Hokkaido University)
Cited by 1
Related Papers
STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization
|Journal of Biological Chemistry|2017|36